Systematic review of exhaled breath VOCs analysis and detection component for human diseases

2021 ◽  
Vol 24 (1) ◽  
pp. 19-31
Author(s):  
Toshiro MATSUMURA ◽  
Yukitoki MORITA ◽  
Shiro IKEDA ◽  
Takemi ARIMOTO ◽  
Kunitoshi MATSUNOBU
RSC Advances ◽  
2019 ◽  
Vol 9 (64) ◽  
pp. 37245-37257 ◽  
Author(s):  
Qiang Yang ◽  
Ai-hua Zhang ◽  
Jian-hua Miao ◽  
Hui Sun ◽  
Ying Han ◽  
...  

Given the highly increased incidence of human diseases, a better understanding of the related mechanisms regarding endogenous metabolism is urgently needed.


Oncotarget ◽  
2015 ◽  
Vol 6 (36) ◽  
pp. 38643-38657 ◽  
Author(s):  
Agne Krilaviciute ◽  
Jonathan Alexander Heiss ◽  
Marcis Leja ◽  
Juozas Kupcinskas ◽  
Hossam Haick ◽  
...  

2020 ◽  
Vol 10 (15) ◽  
pp. 5135
Author(s):  
Nuria Caballé-Cervigón ◽  
José L. Castillo-Sequera ◽  
Juan A. Gómez-Pulido ◽  
José M. Gómez-Pulido ◽  
María L. Polo-Luque

Human healthcare is one of the most important topics for society. It tries to find the correct effective and robust disease detection as soon as possible to patients receipt the appropriate cares. Because this detection is often a difficult task, it becomes necessary medicine field searches support from other fields such as statistics and computer science. These disciplines are facing the challenge of exploring new techniques, going beyond the traditional ones. The large number of techniques that are emerging makes it necessary to provide a comprehensive overview that avoids very particular aspects. To this end, we propose a systematic review dealing with the Machine Learning applied to the diagnosis of human diseases. This review focuses on modern techniques related to the development of Machine Learning applied to diagnosis of human diseases in the medical field, in order to discover interesting patterns, making non-trivial predictions and useful in decision-making. In this way, this work can help researchers to discover and, if necessary, determine the applicability of the machine learning techniques in their particular specialties. We provide some examples of the algorithms used in medicine, analysing some trends that are focused on the goal searched, the algorithm used, and the area of applications. We detail the advantages and disadvantages of each technique to help choose the most appropriate in each real-life situation, as several authors have reported. The authors searched Scopus, Journal Citation Reports (JCR), Google Scholar, and MedLine databases from the last decades (from 1980s approximately) up to the present, with English language restrictions, for studies according to the objectives mentioned above. Based on a protocol for data extraction defined and evaluated by all authors using PRISMA methodology, 141 papers were included in this advanced review.


2013 ◽  
Vol 48 (5) ◽  
pp. 419-442 ◽  
Author(s):  
P.S. Thomas ◽  
A.J. Lowe ◽  
P. Samarasinghe ◽  
C.J. Lodge ◽  
Y. Huang ◽  
...  

Author(s):  
Dayle Terrington ◽  
Conal Hayton ◽  
Adam Peel ◽  
Stephen Fowler ◽  
Andrew Wilson

2018 ◽  
Vol 12 (2) ◽  
pp. 024001 ◽  
Author(s):  
Pouline M van Oort ◽  
Pedro Povoa ◽  
Ronny Schnabel ◽  
Paul Dark ◽  
Antonio Artigas ◽  
...  

2017 ◽  
Vol 11 (1) ◽  
pp. 016011 ◽  
Author(s):  
Adam M Peel ◽  
Christina-Jane Crossman-Barnes ◽  
Jonathan Tang ◽  
Stephen J Fowler ◽  
Gwyneth A Davies ◽  
...  

2017 ◽  
Vol 20 ◽  
pp. 59-73 ◽  
Author(s):  
Timothy L. Edwards ◽  
Clare M. Browne ◽  
Adee Schoon ◽  
Christophe Cox ◽  
Alan Poling

Author(s):  
Fares Gouzi ◽  
Diba Ayache ◽  
Christophe Hedon ◽  
Nicolas Molinari ◽  
Aurore Vicet

Abstract Introduction: Exhaled breath acetone (ExA) has been investigated as a biomarker for heart failure (HF). Yet, barriers to its use in the clinical field have not been identified. The aim of this systematic review and meta-analysis was to assess the ExA heterogeneity and factors of variability in healthy controls (HC), to identify its relations with HF diagnosis and prognostic factors and to assess its diagnosis and prognosis accuracy in HF patients. Methods: A systematic search was conducted in PUBMED and Web of Science database. All studies with HC and HF patients with a measured ExA were included and studies providing ExA’s diagnosis and prognosis accuracy were identified. Results: Out of 971 identified studies, 18 studies involving 833 HC and 1009 HF patients were included in the meta-analysis. In HC, ExA showed an important heterogeneity (I²=99%). Variability factors were fasting state, sampling type and analytical method. The mean ExA was 1.89 times higher in HF patients vs. HC (782 [531-1032] vs. 413 [347-478] ppbv; p<0.001). One study showed excellent diagnosis accuracy, and one showed a good prognosis value. ExA correlated with New York Heart Association (NYHA) dyspnea (p<0.001) and plasma brain natriuretic peptide (p<0.001). Studies showed a poor definition and reporting of included subjects. Discussion: Despite the between-study heterogeneity in HC, the evidence of an excellent diagnosis and prognosis value of ExA in HF from single studies can be extended to clinical populations worldwide. Factors of variability (ExA procedure and breath sampling) could further improve the diagnosis and prognosis values of this biomarker in HF patients.


2019 ◽  
Vol 13 (3) ◽  
pp. 036015 ◽  
Author(s):  
Dayle L Terrington ◽  
Conal Hayton ◽  
Adam Peel ◽  
Stephen J Fowler ◽  
William Fraser ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document